查看購物車
  • English
  • Japanese
診斷領域質譜和層析法市場：全球和區域分析：按產品類型、應用類型、檢體類型、測試類型和國家/地區分類 - 分析和預測（2025-2035 年）
市場調查報告書
商品編碼
2032109

診斷領域質譜和層析法市場：全球和區域分析：按產品類型、應用類型、檢體類型、測試類型和國家/地區分類 - 分析和預測（2025-2035 年）

Mass Spectrometry and Chromatography in Diagnostics Market - A Global and Regional Analysis: Focus on Product Type, Application Type, Sample Type, Testing Type, and Country - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 228 Pages | 商品交期: 1-5個工作天內

價格

2024 年全球質譜和層析法診斷市場規模為 7.975 億美元，預計到 2035 年將達到 17.247 億美元，2025 年至 2035 年的複合年成長率為 7.54%。

質譜和層析法市場是更廣泛的分析和生命科學儀器領域的重要組成部分。這兩種技術為化學和生物物質的分離、鑑定和定量提供了先進的方法，在推動製藥、環境監測、診斷和食品安全等多個領域的進步方面發揮著至關重要的作用。在診斷應用中，這些技術很少單獨使用，而是整合到工作流程中。例如，液相層析法聯用技術結合了液相層析法的分離能力和質譜的質量分析能力。這種整合在分析複雜樣品時特別有效，因為在這些樣品中，需要先分離各組分才能確定其品質或結構。此類混合系統對於臨床環境中患者樣本的高通量分析至關重要，能夠提供全面的信息，從而指南診斷和治療。質譜和層析法在診斷領域的主要應用包括維生素譜分析和荷爾蒙譜分析。

關鍵市場統計數據
預測期 2025-2035
2025年市場規模 8.34億美元
2035 年預測 17.247億美元
複合年成長率 7.54%

市場概覽

質譜和層析法技術在診斷領域正經歷快速成長，這主要得益於這些技術相比傳統免疫檢測所具有的諸多優勢。此外，這些技術的不斷進步也進一步加速了它們的應用。然而，設備成本高昂和熟練專業人員短缺預計將阻礙全球質譜和層析法技術在診斷領域的市場成長。

此外，液相層析法-串聯式質譜質譜（LC-MS/MS）正日益成為標準的診斷技術。 LC-MS/MS在診斷領域日益受到重視，源自於其無可比擬的分析優勢。這些優勢包括卓越的特異性、靈敏度以及進行多項檢測的能力——這些都是複雜診斷任務的關鍵特性。此外，將自動化樣品製備系統整合到基於質譜的診斷中，是臨床檢查室操作的重大進展。在對更快、更準確的診斷檢測日益成長的需求以及技術的不斷進步的推動下，這一趨勢預計將持續發展。

對產業的影響

這項技術在藥物監測、維生素分析、荷爾蒙分析、新生兒篩檢和感染疾病等診斷應用中發揮著至關重要的作用。

市場區隔:

細分 1：按產品類型

  • 樣品製備
  • 質譜和層析法

在診斷用質譜和層析法市場（按產品類型分類）中，質譜和層析法領域佔據主導地位。

全球診斷用質譜和層析法市場（按產品類型分類）主要由質譜和層析法市場主導，預計到 2024 年，該細分市場將佔市場佔有率的 85.34%。質譜和層析法設備的高成本以及診斷中耗材的持續使用支撐了這一主導地位。

細分 2：按應用

  • 藥物監測
  • 維他命
  • 荷爾蒙
  • 甲基丙二酸
  • 免疫抑制劑
  • 臨床毒理學
  • 其他

在診斷用質譜和層析法市場（按應用領域分類）中，維生素產業佔據主導地位。

全球質譜和層析法市場（按應用領域分類）主要由維生素領域主導，預計2024年將佔據20.70%的市場。這一主導地位主要歸功於維生素檢測量巨大，而這又是由常規健康檢查、預防性醫療保健計劃和慢性病監測等因素所推動的。這些檢測服務對象廣泛，且患者需要長期重複進行，導致持續且大規模的檢測需求。

細分3：依檢體類型

  • 血
  • 尿
  • 血清
  • 電漿
  • 唾液

預計血清將成為質譜和層析法診斷市場（按檢體類型分類）的主要樣本。

2024年，血清在全球診斷質譜和層析法市場（檢體類型分類）中表現優於其他細分市場，這主要得益於其廣泛的應用範圍，涵蓋從激素譜分析到維生素分析等諸多領域。這使得血清成為進行精準、全面診斷檢測的理想檢體類型。同時，尿液預計將成為成長最快的細分市場，在2025年至2035年的預測期內，其複合年成長率（CAGR）將達到9.12%。

細分 4：按測試類型

  • 實驗室開發的測試
  • 商業測試

在診斷用質譜和層析法市場（按測試類型分類）中，實驗室開發的測試預計將佔據主導地位。

2024年，在全球用於診斷的質譜和層析法市場（按檢測類型分類）中，實驗室自建檢測方法（LDT）的表現優於商業化檢測方法。同時，在2025年至2035年的預測期內，商業化檢測方法預計將成為成長最快的細分市場，複合年成長率（CAGR）為7.97%。

細分5：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 義大利
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他

北美在診斷領域的質譜和層析法市場（按地區分類）主導。

全球診斷領域質譜和層析法市場（按地區分類）由北美主導，預計到2024年將佔據45.10%的市場佔有率，並在整個預測期內保持這一地位。該地區，尤其是美國，擁有先進的醫療保健基礎設施，有利於包括質譜和層析法的尖端醫療技術的應用。此外，北美還擁有眾多診斷領域質譜和層析法市場的主要企業，例如安捷倫科技、賽默飛世爾科技和丹納赫公司。這些企業的強大實力和持續創新正在推動診斷領域質譜和層析法市場的成長。

質譜和層析法診斷市場近期趨勢

  • 2025年7月，沃特世公司和BD公司達成協議，將BD的生物科學和診斷解決方案業務併入沃特世公司。這將增強兩家公司在液相層析法和質譜領域的實力，擴大其受監管的大通量檢測能力，並加速其在生命科學和診斷市場的成長。
  • 2025 年 6 月，布魯克公司推出了「proteoElute」納流液相層析系統，該系統結合了先進的系統監測、改進的穩健性和減少複雜、低容量樣品中的殘留，從而實現了超靈敏、可靠的多組體學和蛋白​​質組學分析。
  • 2025 年 5 月，布魯克公司推出了 timsOmni 質譜儀，將 timsTOF 的性能與基於 Omnitrap 的多模態碎片化和先進的自上而下蛋白質組學功能相結合，從而能夠進行詳細的、高速的蛋白質定序和精確的轉譯後修飾分析。
  • 2025 年 4 月，布魯克公司收購了 RECIPE Chemicals+Instruments 的多數股權，透過擴大高通量、無層析法和基於 LC 的治療監測分析的獲取途徑，加強了其臨床質譜產品組合，從而提高了實驗室效率、永續性和診斷通量。

需求——促進因素、挑戰與機遇

市場促進因素

質譜和層析法技術的持續進步顯著提升了診斷能力，並克服了傳統方法的局限性，例如靈敏度低和交叉反應。高靈敏度聯用技術的出現，使得更準確、快速且高通量的分子分析成為可能，從而增強了臨床決策能力。隨著這些創新技術的不斷發展，預計將推動診斷市場的更廣泛應用和持續成長。

市場限制因素

高昂的初始投資成本：質譜和層析法系統高昂的初始投資成本是其普及應用的主要障礙，尤其是在資源有限的小規模檢查室和醫療機構。除了大量的初步投資外，持續的營運成本也進一步限制了這些先進診斷技術的應用。透過租賃等靈活的模式來解決這些財務限制，對於擴大市場滲透率至關重要。

市場機遇

聚焦新興市場，拓展質譜和層析法在診斷領域的應用——非洲和亞洲部分地區等新興市場，由於目前質譜和層析法的應用率較低且診斷需求尚未得到滿足，因此為這些技術在診斷領域的應用提供了巨大的成長機會。透過提供價格合理、操作簡便的系統以及舉措本地化培訓，可以有效解決高成本和缺乏技術專長等關鍵障礙，從而促進質譜和色譜技術的更廣泛應用。預計在這些地區進行策略性擴張將釋放巨大的市場潛力，並提升診斷能力。

這份報告將為貴公司帶來哪些附加價值？

產品與創新策略：全球診斷領域的質譜和層析法市場根據各種類別進行細分，包括產品類型、應用類型、檢體類型、測試類型和地區。

成長和行銷策略——夥伴關係、聯盟、資金籌措、新產品發布和業務擴張——在質譜和層析法診斷市場的所有重大發展中佔最大比例。

競爭策略－全球診斷領域的質譜和層析法市場由許多上市和私人公司組成。本研究分析和介紹的診斷領域質譜和層析法市場的主要參與企業包括提供多種產品類型的老字型大小企業。

調查方法

市場設計與檢驗的關鍵考量與假設

  • 全球市場規模估算涵蓋 2024 年至 2035 年期間，其中 2024 年為基準年，2025 年至 2035 年為預測期。
  • 預計未來質譜和層析法在診斷領域的市場佔有率將大幅成長，這一預測是基於對現有解決方案歷史數據的分析。
  • 每家公司的企業收益均以 2023 會計年度及 2024 會計年度的年度報告為準。對於私人公司，企業收益是根據一手研究數據、資金籌措歷史、市場合作關係和業務表現估算得出的。
  • 本報告涵蓋質譜和層析法儀器、耗材和軟體，以及與這些技術中的樣品製備相關的儀器和耗材。此外，本報告重點關注治療藥物監測、維生素分析、荷爾蒙譜分析、免疫抑制劑、甲基丙二酸、臨床毒理學、新生兒篩檢和感染疾病等應用。
  • 此外，食品檢測、環境檢測和化學檢測等其他應用不在本報告的範圍內。服務也不在本研究的涵蓋範圍內。

主要市場參與企業及競爭格局概述

本報告中介紹的公司簡介是根據領先專家提供的資訊以及對每家公司的業務範圍、產品系列和市場滲透率的分析而選擇的。

該市場的主要企業包括以下幾家：

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • Tecan Group Ltd.
  • Danaher Corporation
  • Shimadzu Corporation
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • Restek Corporation
  • Gerstel GmbH & Co. KG
  • Bruker
  • New England Biolabs
  • Hamilton Company
  • VWR International, LLC
  • Chromsystems Instruments & Chemicals GmbH
  • Zivak
  • SENTINEL CH. SpA

目錄

執行摘要

第1章 市場：產業展望

  • 市場概覽
  • 主要趨勢
    • 關鍵趨勢的機會評估
    • 過渡到使用液相層析法串聯式質譜質譜（LC-MS/MS）作為診斷中的標準技術。
    • 利用自動化樣品預處理技術
  • 產品基準測試
  • 監理情勢
    • 美國法規結構
    • 歐洲法規結構
    • 亞太地區的法規結構
  • 市場動態
    • 影響分析
    • 市場促進因素
    • 市場限制因素
    • 市場機遇

第2章 產品類型

  • 產品類型概述
  • 成長佔有率矩陣
  • 樣品製備
    • 裝置
    • 試劑和試劑盒
  • 質譜和層析法
    • 消耗品
    • 裝置
    • 數據分析軟體

第3章：應用程式類型

  • 應用程式類型摘要
  • 成長佔有率矩陣
  • 治療藥物監測
  • 維他命
    • 維生素A
    • 維生素B1
    • 維生素B6
    • 維生素E
    • 其他
  • 荷爾蒙
    • 甲氧基腎上腺素
    • 兒茶酚胺
    • 類固醇
    • 其他
  • 甲基丙二酸（MMA）
  • 免疫抑制劑
  • 臨床毒理學
  • 其他

第4章：檢體型

  • 檢體類型匯總
  • 成長佔有率矩陣
  • 血
  • 尿
  • 血清
  • 電漿
  • 唾液

第5章：測試類型

  • 測試類型概述
  • 成長佔有率矩陣
  • 檢查室開發的測試
  • 市售檢測套組

第6章 區域

  • 區域概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第7章 市場－競爭標竿分析與公司概況

  • 公司關鍵策略及發展現狀
  • 企業競賽矩陣
  • 企業市場占有率分析
  • 公司簡介
    • Agilent Technologies, Inc.
    • Bruker Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
    • Tecan Group Ltd.
    • Danaher Corporation
    • Shimadzu Corporation
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • PerkinElmer Inc.
    • Promega Corporation
    • Restek Corporation
    • New England Biolabs
    • Hamilton Company
    • Avantor, Inc. (VWR International, LLC.)
    • Chromsystems Instruments & Chemicals GmbH.
    • Zivak
    • SENTINEL CH. SpA
    • GERSTEL GmbH & Co. KG

第8章：調查方法

Product Code: BHL2118SB

This report can be delivered within 1 working day.

Introduction of Mass Spectrometry and Chromatography in Diagnostics Market

The global mass spectrometry and chromatography in diagnostics market was valued at $797.5 million in 2024 and is expected to reach $1,724.7 million by 2035, growing at a CAGR of 7.54% between 2025 and 2035. The mass spectrometry and chromatography markets are critical components of the broader analytical and life sciences instrumentation sector. Both technologies offer sophisticated methods for the separation, identification, and quantification of chemical and biological substances and have been instrumental in driving advances across a variety of fields, including pharmaceuticals, environmental monitoring, diagnostics, and food safety, among others. For diagnostics applications, these technologies are mostly not used in isolation but are integrated into workflows. For instance, liquid chromatography-mass spectrometry combines the separation capabilities of liquid chromatography with the mass analysis power of mass spectrometry. This integration is particularly effective in complex sample analysis, where components need to be separated before their mass and structure can be determined. Such hybrid systems are critical in clinical settings for the high-throughput analysis of patient samples, offering a comprehensive understanding that guides diagnosis and treatment. The key applications of mass spectrometry and chromatography in diagnostics include vitamin profiling and hormone profiling, among others.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$834.0 Million
2035 Forecast$1,724.7 Million
CAGR7.54%

Market Introduction

The mass spectrometry and chromatography in diagnostics market is experiencing rapid growth, driven by multiple benefits offered by the technologies as compared to the traditional immunoassays, and continuous technological advancements in these technologies are further advancing their adoption. However, the high cost of acquisition of instrumentation, as well as the dearth of skilled professionals, is expected to hinder the growth of the global mass spectrometry and chromatography in diagnostics market.

Furthermore, there has been a shift toward the utilization of liquid chromatography-tandem mass spectrometry (LC-MS/MS) as a standard technique in diagnostics. The growing preference for LC-MS/MS in diagnostics is driven by its unparalleled analytical advantages, which include exceptional specificity, sensitivity, and the ability to conduct multiplex testing, qualities that are indispensable for complex diagnostic tasks. In addition to this, the integration of automated sample preparation systems in mass spectrometry-based diagnostics marks a pivotal advancement in clinical laboratory operations. This trend will continue to expand, driven by the increasing demands for faster, more accurate diagnostic testing and the ongoing advancements in technology.

Industrial Impact

This technology has a pivotal role in diagnostic applications such as therapeutic drug monitoring, vitamin analysis, hormone profiling, newborn screening, and infectious diseases, among others.

Market Segmentation:

Segmentation 1: by Product Type

  • Sample Preparation
  • Mass Spectrometry and Chromatography

Mass Spectrometry and Chromatography Segment to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type)

The global mass spectrometry and chromatography in diagnostics market (by product type) has been dominated by the mass spectrometry and chromatography segment, which held 85.34% of the market share in 2024. This dominance has been driven by the high cost of the instrumentation of mass spectrometry and chromatography, and the recurring use of consumables in diagnostics.

Segmentation 2: by Application Type

  • Therapeutic Drug Monitoring
  • Vitamins
  • Hormones
  • Methylmalonic Acid
  • Immunosuppressants
  • Clinical Toxicology
  • Others

Vitamins Segment to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type)

The global mass spectrometry and chromatography in diagnostics market (by application type) has been dominated by the vitamins segment, which held 20.70% of the market share in 2024. This dominance is primarily due to their exceptionally high testing volumes driven by routine health checkups, preventive care programs, and chronic disease monitoring. These assays are ordered across a broad patient base and frequently repeated over time, resulting in sustained, large-scale testing demand.

Segmentation 3: by Sample Type

  • Blood
  • Urine
  • Serum
  • Plasma
  • Saliva

Serum to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Type)

In 2024, serum outweighed the other segments in the global mass spectrometry and chromatography in diagnostics market (by sample type) due to its suitability for a broad spectrum of applications, from hormone profiling to vitamin analysis. This makes serum an ideal sample type for precise and comprehensive diagnostic tests. On the other hand, urine is expected to be the fastest-growing segment with a CAGR of 9.12% in the forecast period 2025-2035.

Segmentation 4: by Testing Type

  • Laboratory-Developed Tests
  • Commercial Assays

Laboratory-Developed Tests to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Testing Type)

In 2024, laboratory-developed tests outweighed the commercial assays segment in the global mass spectrometry and chromatography in diagnostics market (by testing type). On the other hand, the commercial assay segment is expected to be the fastest-growing segment with a CAGR of 7.97% in the forecast period 2025-2035.

Segmentation 5: by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Spain
    • Italy
    • France
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest-of-Middle East and Africa

North America to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Region)

The global mass spectrometry and chromatography in diagnostics market (by region) has been dominated by North America, which held 45.10% of the market share in 2024 and is anticipated to retain its position in the market during the forecast period. The region boasts an advanced healthcare infrastructure, particularly in the U.S., which facilitates the adoption of cutting-edge medical technologies, including mass spectrometry and chromatography. Additionally, North America is the hub to many leading companies in the mass spectrometry and chromatography in diagnostics market, such as Agilent Technologies, Inc., Thermo Fisher Scientific Inc., and Danaher Corporation, among others, whose strong presence and continuous innovation drive the growth of the mass spectrometry and chromatography in diagnostics market.

Recent Developments in the Mass Spectrometry and Chromatography in Diagnostics Market

  • In July 2025, Waters Corporation and BD agreed to combine BD's Biosciences & Diagnostic Solutions business with Waters Corporation to strengthen their liquid chromatography and mass spectrometry portfolio, expanding high-volume, regulated testing capabilities and accelerating growth across life science and diagnostic markets.
  • In June 2025, Bruker Corporation launched the proteoElute nanoflow LC system to enable ultra-sensitive and reliable multiomics and proteomics analyses by combining advanced system monitoring, improved robustness, and reduced carryover for complex and low-input samples.
  • In May 2025, Bruker Corporation launched the timsOmni mass spectrometer to enable deep, high-speed proteoform sequencing and precise post-translational modification analysis by integrating timsTOF performance with Omnitrap-based multimodal fragmentation and advanced top-down proteomics capabilities.
  • In April 2025, Bruker Corporation made a majority investment in RECIPE Chemicals + Instruments to strengthen its clinical mass spectrometry portfolio by expanding access to high-throughput, chromatography-free, and LC-based therapeutic drug monitoring assays, improving laboratory efficiency, sustainability, and diagnostic throughput.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

Continuous Technological Advancements in Mass Spectrometry and Chromatography: Technological advancements are significantly enhancing diagnostic capabilities, addressing the limitations of traditional methods such as low sensitivity and cross-reactivity. The emergence of high-sensitivity and hyphenated techniques is enabling more accurate, rapid, and high-throughput molecular analysis, thereby strengthening clinical decision-making. As these innovations continue to evolve, they are expected to drive broader adoption and sustained growth in the diagnostics market.

Market Restraints:

High Initial Set-up Cost: The high cost of acquisition associated with mass spectrometry and chromatography systems poses a significant barrier to adoption, particularly for smaller laboratories and resource-constrained healthcare settings. Substantial upfront investments, coupled with ongoing operational expenses, limit accessibility to these advanced diagnostic technologies. Addressing these financial constraints through flexible models such as leasing or rentals will be critical to enabling broader market adoption.

Market Opportunities:

Focus on Emerging Markets for Expansion of Mass Spectrometry and Chromatography in Diagnostics: Emerging markets present significant growth opportunities for mass spectrometry and chromatography in diagnostics, driven by low current penetration and unmet diagnostic needs across regions such as Africa and parts of Asia. Addressing key barriers such as high costs and limited technical expertise through affordable, user-friendly systems and local training initiatives can enable wider adoption. Strategic expansion in these regions is expected to unlock substantial market potential and enhance diagnostic capabilities.

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The global mass spectrometry and chromatography in diagnostics market has been segmented based on various categories, such as by product type, application type, sample type, testing type, and region.

Growth/Marketing Strategy: Partnerships, alliances, funding, new offerings, and business expansions together accounted for the maximum number of key developments of the total developments in the mass spectrometry and chromatography in diagnostics market.

Competitive Strategy: The global mass spectrometry and chromatography in diagnostics market consists of various public and a few private companies. Key players in the mass spectrometry and chromatography in diagnostics market, analyzed and profiled in the study involve established players that offer various kinds of products.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2024 to 2035 have been considered for the global market size estimation, 2024 has been considered as the base year, and 2025 to 2035 as the forecast period.
  • The market contribution of mass spectrometry and chromatography in diagnostics is anticipated to grow substantially in the future, with projections based on historical analysis of available solutions.
  • Revenues from companies have been sourced from their annual reports for FY2023 and FY2024. For private companies, revenue estimates are derived from primary research inputs, funding history, market collaborations, and operational performance.
  • The report includes mass spectrometry and chromatography instruments, consumables, and software. The report also covers instruments and consumables involved in the sample preparation of these technologies. Additionally, the report only focuses on applications such as therapeutic drug monitoring, vitamin analysis, hormone profiling, immunosuppressants, methylmalonic acids, clinical toxicology, newborn screening, and infectious diseases, among others.
  • Furthermore, other applications, such as food testing, environmental testing, and chemicals, have been excluded from the scope of the report. Additionally, services are not part of the study.

Primary Research

The primary sources involve industry experts in mass spectrometry and chromatography in diagnostics. Key opinion leaders (KOLs) such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of the report's segmentation and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of the different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

Some of the prominent companies in this market are:

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • Tecan Group Ltd.
  • Danaher Corporation
  • Shimadzu Corporation
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • Restek Corporation
  • Gerstel GmbH & Co. KG
  • Bruker
  • New England Biolabs
  • Hamilton Company
  • VWR International, LLC
  • Chromsystems Instruments & Chemicals GmbH
  • Zivak
  • SENTINEL CH. SpA

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Overview
  • 1.2 Key Trends
    • 1.2.1 Opportunity Assessment of Key Trends
    • 1.2.2 Shift toward Utilization of Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) as Standard Technique in Diagnostics
    • 1.2.3 Utilization of Automated Sample Preparation Technologies
  • 1.3 Product Benchmarking
  • 1.4 Regulatory Landscape
    • 1.4.1 Regulatory Framework in the U.S.
      • 1.4.1.1 Recommendations for Diagnostic Approval
    • 1.4.2 Regulatory Framework in Europe
      • 1.4.2.1 Recommendations for Diagnostic Approval
    • 1.4.3 Regulatory Framework in Asia-Pacific
      • 1.4.3.1 China
  • 1.5 Market Dynamics
    • 1.5.1 Impact Analysis
    • 1.5.2 Market Drivers
      • 1.5.2.1 Continuous Technological Advancements in Mass Spectrometry and Chromatography Instruments
      • 1.5.2.2 Shift from Traditional Methods to Mass Spectrometry and Chromatography in Clinical Diagnostics
    • 1.5.3 Market Restraints
      • 1.5.3.1 High Initial Set-Up Cost
      • 1.5.3.2 Skill Gap and Dearth of Skilled Professionals
    • 1.5.4 Market Opportunities
      • 1.5.4.1 Focus on Emerging Markets for Expansion of Mass Spectrometry and Chromatography in Diagnostics

2 Product Type

  • 2.1 Product Type Summary
  • 2.2 Growth-Share Matrix
  • 2.3 Sample Preparation
    • 2.3.1 Instruments
      • 2.3.1.1 Manual Sample Preparation Instruments
      • 2.3.1.2 Automated Sample Preparation Instruments
      • 2.3.1.3 Integrated Sample Preparation Instruments
    • 2.3.2 Reagents and Kits
      • 2.3.2.1 Sample Lysis and Extraction Kits
      • 2.3.2.2 Depletion and Enrichment Kits
      • 2.3.2.3 Clean-Up Kits
      • 2.3.2.4 Digestion Kits
      • 2.3.2.5 Accessories
  • 2.4 Mass Spectrometry and Chromatography
    • 2.4.1 Consumables
      • 2.4.1.1 Kits
      • 2.4.1.2 Calibration Solutions
      • 2.4.1.3 Controls and Standards
      • 2.4.1.4 Solvents
      • 2.4.1.5 Columns
      • 2.4.1.6 Vials
    • 2.4.2 Instruments
      • 2.4.2.1 Mass Spectrometry
      • 2.4.2.2 Liquid Chromatography
      • 2.4.2.3 Gas Chromatography
      • 2.4.2.4 Hybrid Mass Spectrometry
    • 2.4.3 Data Analysis Software

3 Application Type

  • 3.1 Application Type Summary
  • 3.2 Growth-Share Matrix
  • 3.3 Therapeutic Drug Monitoring
  • 3.4 Vitamins
    • 3.4.1 Vitamin-A
    • 3.4.2 Vitamin-B1
    • 3.4.3 Vitamin-B6
    • 3.4.4 Vitamin-E
    • 3.4.5 Others
  • 3.5 Hormones
    • 3.5.1 Metanephrines
    • 3.5.2 Catecholamines
    • 3.5.3 Steroids
    • 3.5.4 Others
  • 3.6 Methylmalonic Acid (MMA)
  • 3.7 Immunosuppressants
  • 3.8 Clinical Toxicology
  • 3.9 Others

4 Sample Type

  • 4.1 Sample Type Summary
  • 4.2 Growth-Share Matrix
  • 4.3 Blood
  • 4.4 Urine
  • 4.5 Serum
  • 4.6 Plasma
  • 4.7 Saliva

5 Testing Type

  • 5.1 Testing Type Summary
  • 5.2 Growth-Share Matrix
  • 5.3 Laboratory-Developed Tests
  • 5.4 Commercial Assays

6 Region

  • 6.1 Regional Summary
  • 6.2 North America
    • 6.2.1 Regional Overview
    • 6.2.2 Driving Factors for Market Growth
    • 6.2.3 Factors Challenging the Market
    • 6.2.4 By Product Type
    • 6.2.5 By Application Type
    • 6.2.6 By Country
      • 6.2.6.1 U.S.
        • 6.2.6.1.1 By Product Type
        • 6.2.6.1.2 By Application Type
      • 6.2.6.2 Canada
        • 6.2.6.2.1 By Product Type
        • 6.2.6.2.2 By Application Type
  • 6.3 Europe
    • 6.3.1 Regional Overview
    • 6.3.2 Driving Factors for Market Growth
    • 6.3.3 Factors Challenging the Market
    • 6.3.4 By Product Type
    • 6.3.5 By Application Type
    • 6.3.6 By Country
      • 6.3.6.1 U.K.
        • 6.3.6.1.1 By Product Type
        • 6.3.6.1.2 By Application Type
      • 6.3.6.2 Germany
        • 6.3.6.2.1 By Product Type
        • 6.3.6.2.2 By Application Type
      • 6.3.6.3 France
        • 6.3.6.3.1 By Product Type
        • 6.3.6.3.2 By Application Type
      • 6.3.6.4 Italy
        • 6.3.6.4.1 By Product Type
        • 6.3.6.4.2 By Application Type
      • 6.3.6.5 Spain
        • 6.3.6.5.1 By Product Type
        • 6.3.6.5.2 By Application Type
      • 6.3.6.6 Rest-of-Europe
        • 6.3.6.6.1 By Product Type
        • 6.3.6.6.2 By Application Type
  • 6.4 Asia-Pacific
    • 6.4.1 Regional Overview
    • 6.4.2 Driving Factors for Market Growth
    • 6.4.3 Factors Challenging the Market
    • 6.4.4 By Product Type
    • 6.4.5 By Application Type
    • 6.4.6 By Country
      • 6.4.6.1 Japan
        • 6.4.6.1.1 By Product Type
        • 6.4.6.1.2 By Application Type
      • 6.4.6.2 China
        • 6.4.6.2.1 By Product Type
        • 6.4.6.2.2 By Application Type
      • 6.4.6.3 India
        • 6.4.6.3.1 By Product Type
        • 6.4.6.3.2 By Application Type
      • 6.4.6.4 Rest-of-Asia-Pacific
        • 6.4.6.4.1 By Product Type
        • 6.4.6.4.2 By Application Type
  • 6.5 Latin America
    • 6.5.1 Regional Overview
    • 6.5.2 Driving Factors for Market Growth
    • 6.5.3 Factors Challenging the Market
    • 6.5.4 By Product Type
    • 6.5.5 By Application Type
    • 6.5.6 By Country
      • 6.5.6.1 Brazil
        • 6.5.6.1.1 By Product Type
        • 6.5.6.1.2 By Application Type
      • 6.5.6.2 Mexico
        • 6.5.6.2.1 By Product Type
        • 6.5.6.2.2 By Application Type
      • 6.5.6.3 Rest-of-Latin America
        • 6.5.6.3.1 By Product Type
        • 6.5.6.3.2 By Application Type
  • 6.6 Middle East and Africa
    • 6.6.1 Regional Overview
    • 6.6.2 Driving Factors for Market Growth
    • 6.6.3 Factors Challenging the Market
    • 6.6.4 By Product Type
    • 6.6.5 By Application Type
    • 6.6.6 By Country
      • 6.6.6.1 GCC Countries
        • 6.6.6.1.1 By Product Type
        • 6.6.6.1.2 By Application Type
      • 6.6.6.2 South Africa
        • 6.6.6.2.1 By Product Type
        • 6.6.6.2.2 By Application Type
      • 6.6.6.3 Rest of-Middle East and Africa
        • 6.6.6.3.1 By Product Type
        • 6.6.6.3.2 By Application Type

7 Markets - Competitive Benchmarking & Company Profiles

  • 7.1 Key Strategies and Developments by Company
    • 7.1.1 Mergers and Acquisitions
    • 7.1.2 Partnerships, Collaborations, and Business Expansions
    • 7.1.3 New Offerings
  • 7.2 Company Competition Matrix
  • 7.3 Company Share Analysis
  • 7.4 Company Profiles
    • 7.4.1 Agilent Technologies, Inc.
      • 7.4.1.1 Overview
      • 7.4.1.2 Top Products/Product Portfolio
      • 7.4.1.3 Top Competitors
      • 7.4.1.4 Target Customers
      • 7.4.1.5 Key Personal
      • 7.4.1.6 Analyst View
    • 7.4.2 Bruker Corporation
      • 7.4.2.1 Overview
      • 7.4.2.2 Top Products/Product Portfolio
      • 7.4.2.3 Top Competitors
      • 7.4.2.4 Target Customers
      • 7.4.2.5 Key Personal
      • 7.4.2.6 Analyst View
    • 7.4.3 Thermo Fisher Scientific Inc.
      • 7.4.3.1 Overview
      • 7.4.3.2 Top Products/Product Portfolio
      • 7.4.3.3 Top Competitors
      • 7.4.3.4 Target Customers
      • 7.4.3.5 Key Personal
      • 7.4.3.6 Analyst View
    • 7.4.4 Waters Corporation
      • 7.4.4.1 Overview
      • 7.4.4.2 Top Products/Product Portfolio
      • 7.4.4.3 Top Competitors
      • 7.4.4.4 Target Customers
      • 7.4.4.5 Key Personal
      • 7.4.4.6 Analyst View
    • 7.4.5 Tecan Group Ltd.
      • 7.4.5.1 Overview
      • 7.4.5.2 Top Products/Product Portfolio
      • 7.4.5.3 Top Competitors
      • 7.4.5.4 Target Customers
      • 7.4.5.5 Key Personal
      • 7.4.5.6 Analyst View
    • 7.4.6 Danaher Corporation
      • 7.4.6.1 Overview
      • 7.4.6.2 Top Products/Product Portfolio
      • 7.4.6.3 Top Competitors
      • 7.4.6.4 Target Customers
      • 7.4.6.5 Key Personal
      • 7.4.6.6 Analyst View
    • 7.4.7 Shimadzu Corporation
      • 7.4.7.1 Overview
      • 7.4.7.2 Top Products/Product Portfolio
      • 7.4.7.3 Top Competitors
      • 7.4.7.4 Target Customers
      • 7.4.7.5 Key Personal
      • 7.4.7.6 Analyst View
    • 7.4.8 Merck KGaA
      • 7.4.8.1 Overview
      • 7.4.8.2 Top Products/Product Portfolio
      • 7.4.8.3 Top Competitors
      • 7.4.8.4 Target Customers
      • 7.4.8.5 Key Personal
      • 7.4.8.6 Analyst View
    • 7.4.9 Bio-Rad Laboratories, Inc.
      • 7.4.9.1 Overview
      • 7.4.9.2 Top Products/Product Portfolio
      • 7.4.9.3 Top Competitors
      • 7.4.9.4 Target Customers
      • 7.4.9.5 Key Personal
      • 7.4.9.6 Analyst View
    • 7.4.10 PerkinElmer Inc.
      • 7.4.10.1 Overview
      • 7.4.10.2 Top Products/Product Portfolio
      • 7.4.10.3 Top Competitors
      • 7.4.10.4 Target Customers
      • 7.4.10.5 Key Personal
      • 7.4.10.6 Analyst View
    • 7.4.11 Promega Corporation
      • 7.4.11.1 Overview
      • 7.4.11.2 Top Products/Product Portfolio
      • 7.4.11.3 Top Competitors
      • 7.4.11.4 Target Customers
      • 7.4.11.5 Key Personal
      • 7.4.11.6 Analyst View
    • 7.4.12 Restek Corporation
      • 7.4.12.1 Overview
      • 7.4.12.2 Top Products/Product Portfolio
      • 7.4.12.3 Top Competitors
      • 7.4.12.4 Target Customers
      • 7.4.12.5 Key Personal
      • 7.4.12.6 Analyst View
    • 7.4.13 New England Biolabs
      • 7.4.13.1 Overview
      • 7.4.13.2 Top Products/Product Portfolio
      • 7.4.13.3 Top Competitors
      • 7.4.13.4 Target Customers
      • 7.4.13.5 Key Personal
      • 7.4.13.6 Analyst View
    • 7.4.14 Hamilton Company
      • 7.4.14.1 Overview
      • 7.4.14.2 Top Products/Product Portfolio
      • 7.4.14.3 Top Competitors
      • 7.4.14.4 Target Customers
      • 7.4.14.5 Key Personal
      • 7.4.14.6 Analyst View
    • 7.4.15 Avantor, Inc. (VWR International, LLC.)
      • 7.4.15.1 Overview
      • 7.4.15.2 Top Products/Product Portfolio
      • 7.4.15.3 Top Competitors
      • 7.4.15.4 Target Customers
      • 7.4.15.5 Key Personal
      • 7.4.15.6 Analyst View
    • 7.4.16 Chromsystems Instruments & Chemicals GmbH.
      • 7.4.16.1 Overview
      • 7.4.16.2 Top Products/Product Portfolio
      • 7.4.16.3 Top Competitors
      • 7.4.16.4 Target Customers
      • 7.4.16.5 Key Personal
      • 7.4.16.6 Analyst View
    • 7.4.17 Zivak
      • 7.4.17.1 Overview
      • 7.4.17.2 Top Products/Product Portfolio
      • 7.4.17.3 Top Competitors
      • 7.4.17.4 Target Customers
      • 7.4.17.5 Key Personal
      • 7.4.17.6 Analyst View
    • 7.4.18 SENTINEL CH. SpA
      • 7.4.18.1 Overview
      • 7.4.18.2 Top Products/Product Portfolio
      • 7.4.18.3 Top Competitors
      • 7.4.18.4 Target Customers
      • 7.4.18.5 Key Personal
      • 7.4.18.6 Analyst View
    • 7.4.19 GERSTEL GmbH & Co. KG
      • 7.4.19.1 Overview
      • 7.4.19.2 Top Products/Product Portfolio
      • 7.4.19.3 Top Competitors
      • 7.4.19.4 Target Customers
      • 7.4.19.5 Key Personal
      • 7.4.19.6 Analyst View

8 Research Methodology

  • 8.1 Data Sources
    • 8.1.1 Primary Data Sources
    • 8.1.2 Secondary Data Sources
    • 8.1.3 Data Triangulation
  • 8.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Scenario), $Million, 2024, 2030, and 2035
  • Figure 2: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Region), $Million, 2024, 2030, and 2035
  • Figure 3: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024, 2030, and 2035
  • Figure 4: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Application), $Million, 2024, 2030, and 2035
  • Figure 5: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Type), $Million, 2024, 2030, and 2035
  • Figure 6: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Testing Type), $Million, 2024, 2030, and 2035
  • Figure 7: Product Benchmarking (Mass Spectrometry and Chromatography (by Instruments))
  • Figure 8: Regulatory Framework, U.S. FDA
  • Figure 9: EU IVD Regulation
  • Figure 10: Impact Analysis of Market Dynamics, 2024-2035
  • Figure 11: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024, 2030, and 2035
  • Figure 12: Growth-Share Analysis for Global Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), 2024-2035
  • Figure 13: Global Mass Spectrometry and Chromatography in Diagnostics Market (Sample Preparation), $Million, 2024-2035
  • Figure 14: Global Mass Spectrometry and Chromatography in Diagnostics Market (Instruments), $Million, 2024-2035
  • Figure 15: Global Mass Spectrometry and Chromatography in Diagnostics Market (Manual Sample Preparation Instruments), $Million, 2024-2035
  • Figure 16: Global Mass Spectrometry and Chromatography in Diagnostics Market (Automated Sample Preparation Instruments), $Million, 2024-2035
  • Figure 17: Global Mass Spectrometry and Chromatography in Diagnostics Market (Integrated Sample Preparation Instruments), $Million, 2024-2035
  • Figure 18: Global Mass Spectrometry and Chromatography in Diagnostics Market (Reagents and Kits), $Million, 2024-2035
  • Figure 19: Global Mass Spectrometry and Chromatography in Diagnostics Market (Sample Lysis and Extraction Kits), $Million, 2024-2035
  • Figure 20: Global Mass Spectrometry and Chromatography in Diagnostics Market (Depletion and Enrichment Kits), $Million, 2024-2035
  • Figure 21: Global Mass Spectrometry and Chromatography in Diagnostics Market (Clean-Up Kits), $Million, 2024-2035
  • Figure 22: Global Mass Spectrometry and Chromatography in Diagnostics Market (Digestion Kits), $Million, 2024-2035
  • Figure 23: Global Mass Spectrometry and Chromatography in Diagnostics Market (Accessories), $Million, 2024-2035
  • Figure 24: Global Mass Spectrometry and Chromatography in Diagnostics Market (Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Figure 25: Global Mass Spectrometry and Chromatography in Diagnostics Market (Consumables), $Million, 2024-2035
  • Figure 26: Global Mass Spectrometry and Chromatography in Diagnostics Market (Kits), $Million, 2024-2035
  • Figure 27: Global Mass Spectrometry and Chromatography in Diagnostics Market (Calibration Solutions), $Million, 2024-2035
  • Figure 28: Global Mass Spectrometry and Chromatography in Diagnostics Market (Controls and Standards), $Million, 2024-2035
  • Figure 29: Global Mass Spectrometry and Chromatography in Diagnostics Market (Solvents), $Million, 2024-2035
  • Figure 30: Global Mass Spectrometry and Chromatography in Diagnostics Market (Columns), $Million, 2024-2035
  • Figure 31: Global Mass Spectrometry and Chromatography in Diagnostics Market (Vials), $Million, 2024-2035
  • Figure 32: Global Mass Spectrometry and Chromatography in Diagnostics Market (Instruments), $Million, 2024-2035
  • Figure 33: Global Mass Spectrometry and Chromatography in Diagnostics Market (Mass Spectrometry), $Million, 2024-2035
  • Figure 34: Global Mass Spectrometry and Chromatography in Diagnostics Market (Liquid Chromatography), $Million, 2024-2035
  • Figure 35: Global Mass Spectrometry and Chromatography in Diagnostics Market (Gas Chromatography), $Million, 2024-2035
  • Figure 36: Global Mass Spectrometry and Chromatography in Diagnostics Market (Hybrid Mass Spectrometry), $Million, 2024-2035
  • Figure 37: Global Mass Spectrometry and Chromatography in Diagnostics Market (Data Analysis Software), $Million, 2024-2035
  • Figure 38: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024, 2030, and 2035
  • Figure 39: Growth-Share Analysis for Global Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), 2024-2035
  • Figure 40: Global Mass Spectrometry and Chromatography in Diagnostics Market (Therapeutic Drug Monitoring), $Million, 2024-2035
  • Figure 41: Global Mass Spectrometry and Chromatography in Diagnostics Market (Vitamins), $Million, 2024-2035
  • Figure 42: Global Mass Spectrometry and Chromatography in Diagnostics Market (Vitamin-A), $Million, 2024-2035
  • Figure 43: Global Mass Spectrometry and Chromatography in Diagnostics Market (Vitamin-B1), $Million, 2024-2035
  • Figure 44: Global Mass Spectrometry and Chromatography in Diagnostics Market (Vitamin-B6), $Million, 2024-2035
  • Figure 45: Global Mass Spectrometry and Chromatography in Diagnostics Market (Vitamin-E), $Million, 2024-2035
  • Figure 46: Global Mass Spectrometry and Chromatography in Diagnostics Market (Others), $Million, 2024-2035
  • Figure 47: Global Mass Spectrometry and Chromatography in Diagnostics Market (Hormones), $Million, 2024-2035
  • Figure 48: Global Mass Spectrometry and Chromatography in Diagnostics Market (Metanephrines), $Million, 2024-2035
  • Figure 49: Global Mass Spectrometry and Chromatography in Diagnostics Market (Catecholamines), $Million, 2024-2035
  • Figure 50: Global Mass Spectrometry and Chromatography in Diagnostics Market (Steroids), $Million, 2024-2035
  • Figure 51: Global Mass Spectrometry and Chromatography in Diagnostics Market (Others), $Million, 2024-2035
  • Figure 52: Global Mass Spectrometry and Chromatography in Diagnostics Market (Methylmalonic Acid), $Million, 2024-2035
  • Figure 53: Global Mass Spectrometry and Chromatography in Diagnostics Market (Immunosuppresants), $Million, 2024-2035
  • Figure 54: Global Mass Spectrometry and Chromatography in Diagnostics Market (Clinical Toxicology), $Million, 2024-2035
  • Figure 55: Global Mass Spectrometry and Chromatography in Diagnostics Market (Others), $Million, 2024-2035
  • Figure 56: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Type), $Million, 2024, 2030, and 2035
  • Figure 57: Growth-Share Analysis for Global Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Type), 2024-2035
  • Figure 58: Global Mass Spectrometry and Chromatography in Diagnostics Market (Blood), $Million, 2024-2035
  • Figure 59: Global Mass Spectrometry and Chromatography in Diagnostics Market (Urine), $Million, 2024-2035
  • Figure 60: Global Mass Spectrometry and Chromatography in Diagnostics Market (Serum), $Million, 2024-2035
  • Figure 61: Global Mass Spectrometry and Chromatography in Diagnostics Market (Plasma), $Million, 2024-2035
  • Figure 62: Global Mass Spectrometry and Chromatography in Diagnostics Market (Saliva), $Million, 2024-2035
  • Figure 63: Global Mass Spectrometry and Chromatography in Diagnostics Market (by Testing Type), $Million, 2024, 2030, and 2035
  • Figure 64: Growth-Share Analysis for Global Mass Spectrometry and Chromatography in Diagnostics Market (by Testing Type), 2024-2035
  • Figure 65: Global Mass Spectrometry and Chromatography in Diagnostics Market (Laboratory-Developed Tests), $Million, 2024-2035
  • Figure 66: Global Mass Spectrometry and Chromatography in Diagnostics Market (Commercial Assays), $Million, 2024-2035
  • Figure 67: Global Mass Spectrometry and Chromatography in Diagnostics Market, Company Competition Matrix
  • Figure 68: Global Mass Spectrometry and Chromatography in Diagnostics Market, % Share, 2024
  • Figure 69: Data Triangulation
  • Figure 70: Top-Down and Bottom-Up Approach
  • Figure 71: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Current State and Future Potential of Key Trends in the Global Mass Spectrometry and Chromatography in Diagnostics Market
  • Table 3: Immunoassays vs. Mass Spectrometry and Chromatography-Based Methods
  • Table 4: Cost Breakdown for the Acquisition of a Mass Spectrometer System
  • Table 5: Mass Spectrometry and Chromatography in Diagnostics Market (by Region), $Million, 2024-2035
  • Table 6: North America Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 7: North America Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 8: North America Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 9: North America Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 10: North America Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 11: North America Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 12: U.S. Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 13: U.S. Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 14: U.S. Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 15: U.S. Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 16: U.S. Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 17: U.S. Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 18: Canada Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 19: Canada Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 20: Canada Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 21: Canada Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 22: Canada Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 23: Canada Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 24: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 25: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 26: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 27: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 28: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 29: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 30: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 31: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 32: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 33: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 34: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 35: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 36: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 37: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 38: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 39: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 40: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 41: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 42: France Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 43: France Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 44: France Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 45: France Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 46: France Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 47: France Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 48: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 49: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 50: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 51: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 52: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 53: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 54: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 55: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 56: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 57: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 58: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 59: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 60: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 61: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 62: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 63: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 64: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 65: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 66: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 67: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 68: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 69: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 70: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 71: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 72: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 73: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 74: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 75: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 76: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 77: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 78: China Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 79: China Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 80: China Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 81: China Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 82: China Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 83: China Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 84: India Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 85: India Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 86: India Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 87: India Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 88: India Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 89: India Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 90: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 91: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 92: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 93: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 94: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 95: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 96: Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 97: Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 98: Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 99: Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 100: Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 101: Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 102: Brazil Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 103: Brazil Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 104: Brazil Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 105: Brazil Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 106: Brazil Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 107: Brazil Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 108: Mexico Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 109: Mexico Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 110: Mexico Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 111: Mexico Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 112: Mexico Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 113: Mexico Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 114: Rest-of-Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 115: Rest-of-Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 116: Rest-of-Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 117: Rest-of-Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 118: Rest-of-Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 119: Rest-of-Latin America Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 120: Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 121: Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 122: Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 123: Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 124: Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 125: Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 126: GCC Countries Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 127: GCC Countries Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 128: GCC Countries Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 129: GCC Countries Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 130: GCC Countries Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 131: GCC Countries Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 132: South Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 133: South Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 134: South Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 135: South Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 136: South Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 137: South Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035
  • Table 138: Rest-of-Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2024-2035
  • Table 139: Rest-of-Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2024-2035
  • Table 140: Rest-of-Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2024-2035
  • Table 141: Rest-of-Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2024-2035
  • Table 142: Rest-of-Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2024-2035
  • Table 143: Rest-of-Middle East and Africa Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2024-2035